Skip Navigation

European Journal of Heart Failure 2005 7(5):931-936; doi:10.1016/j.ejheart.2005.04.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cleland, J. G.F.
Right arrow Articles by Clark, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleland, J. G.F.
Right arrow Articles by Clark, A. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Clinical trials update from the American College of Cardiology meeting: CARE-HF and the Remission of Heart Failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER

John G.F. Clelanda, Alison P. Colettaa,*, Nick Freemantleb, Periaswamy Velavana, Lwin Tina and Andrew L. Clarka

a Department of Cardiology, University of Hull Castle Hill Hospital, Cottingham, Kingston-upon-Hull, HU15 5JQ, UK
b Department of Primary Care and General Practice University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK

* Corresponding author. Tel.: +44 1482 624086; fax: +44 1482 624085. E-mial address: a.p.coletta{at}hull.ac.uk


  Abstract

This article provides information and a commentary on landmark trials presented at the American College of Cardiology meeting held in March 2005, relevant to the pathophysiology, prevention and treatment of heart failure. All reports should be considered as preliminary data, as analyses may change in the final publication. CARE-HF showed that Cardiac Re-synchronisation Therapy, administered in addition to expert pharmacological management, reduced all cause mortality and CV hospitalisation in patients with moderate or severe heart failure and cardiac dyssynchrony. The Women's Health Study showed no benefit of vitamin E supplementation or aspirin in the primary prevention of CV disease. The TNT study showed that reducing LDL cholesterol to levels lower than currently recommended, produced a 22% reduction in the incidence of major cardiovascular events. In COMPASS, an implantable device that continuously monitors intra-cardiac pressures was shown to be safe and to improve care in patients with chronic heart failure. Tezosentan failed to show benefit in patients with acute heart failure in the VERITAS study. The CANPAP study failed to show a benefit of continuous positive airway pressure on mortality and heart transplantation in heart failure patients with central sleep apnoea. EECP therapy improved exercise capacity but had no effect on peak VO2 in heart failure patients in the PEECH study. In the PREMIER study the matrix metalloproteinase inhibitor PG-116800 failed to prevent LV remodelling following myocardial infarction.

Key Words: CARE-HF and the Remission of Heart Failure • Women's Health Study • TNT • COMPASS-HF • VERITAS • CANPAP • PEECH • PREMIER

Received April 7, 2005; Accepted April 18, 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. G.F. Cleland, L. Tavazzi, J.-C. Daubert, A. Tageldien, and N. Freemantle
Cardiac resynchronization therapy are modern myths preventing appropriate use?
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 608 - 611.
[Full Text] [PDF]

Home page
 CirculationHome page
J. Ritzema, I. C. Melton, A. M. Richards, I. G. Crozier, C. Frampton, R. N. Doughty, J. Whiting, S. Kar, N. Eigler, H. Krum, et al.
Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device
Circulation, December 18, 2007; 116(25): 2952 - 2959.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
F. Braunschweig, A. Fahrleitner-Pammer, M. Mangiavacchi, S. Ghio, P. Fotuhi, U. C. Hoppe, and C. Linde
Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure
Eur J Heart Fail, December 1, 2006; 8(8): 797 - 803.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. L. Clark and J. G.F. Cleland
Anemia and Chronic Heart Failure: Are We Asking the Right Questions?
Circulation, September 20, 2005; 112(12): 1681 - 1683.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.